Figure 1: Differentiation of HAP_R01 and SBA_R01. | Scientific Reports

Figure 1: Differentiation of HAP_R01 and SBA_R01.

From: Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms

Figure 1

(a) Chemical structures of HAP and SBA reference compounds. (b) Activity of HAP and SBA compounds. Shown are mean IC50 values of biochemical quenching assay, mean EC50 values of HepG2.2.15 antiviral assay and mean CC50 values of cytotoxicity experiment (±standard deviation). Each is from three independent experiments. (c) Electrophoresis of core particles in HepG2.2.15 cell lysate. Both tested compounds are effective in reducing encapsidated DNA. HAP_R01-treated cells show concentration-dependent reduction of capsid level on a native agarose gel and core protein level on a denatured gel. In contrast, SBA_R01 does not diminish either capsid level or core protein level at non-cytotoxic concentrations. The cropped DNA and native gels are shown here for clarity. The full-length blots for the DNA and native gels are presented in Supplementary Fig. S13. Actin is the loading control. (d) Electron micrographs of compound-treated core protein assembly at the 1:1 dimer-to-compound ratio. Left: capsid control induced by 250 mM NaCl. Middle: 5 μM core protein dimer incubated with 5 μM HAP_R01. Right: 5 μM core protein dimer incubated with 5 μM SBA_R01. Black scale bar indicates 50 nm.

Back to article page